After the pharmaceutical giant Pfizer announced that it was to close its facility in Shanbally, Cork last year, BioMarin Pharmaceutical has announced it has bought the plant.
US-based biopharmaceutical firm BioMarin is to buy the facility at a cost of EU34m. It will create 100 jobs over the next five years; this will lead to a net gain of 35 jobs. IDA (Industrial Development Agency) Ireland said that it fully supported the investment. BioMarin’s work is concentrated on the treatment of rare…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
